Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
CIPLA Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Strong price momentum
High and stable ROE
High and stable operating margin
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Analysts have been downgrading forward EPS estimates
Low revenue growth and lower than median growth of industry
Low dividend yield
Neutral
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
CIPLA Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
CIPLA Bulk, Block & Insider Trades
CIPLA Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Rights issue
Stock split
Others
Bonus(3 new shares for 2 existing shares)Bonus issue of 466374814 securities. Ex-date: 24th Apr 2006 Announced on: 13th Feb 2006
Bonus(2 new shares for 1 existing shares)Bonus issue. Ex-date: 18th Oct 1999 Announced on: 6th Aug 1999
Bonus(5 new shares for 1 existing shares) Ex-date: 4th Apr 1994 Announced on: 24th Mar 1994
Bonus(1 new shares for 1 existing shares) Ex-date: 6th Oct 1992
Rights issue(4 new shares @ 700 INR for 50 existing shares) Ex-date: 8th Feb 1995 Announced on: 3rd Feb 1995
Stock split(1 : 5)Nominal value change from Rs. 10 to Rs. 2. Ex-date: 12th May 2004 Announced on: 23rd Mar 2004
Stock split(1 : 10) Ex-date: 29th Jul 1994
MergerEquity Shares of Rs. 2/- each (fully paid-up) issued to shareholders of erstwhile Oncocare India Pvt. Ltd Nebumed Pharma Pvt. Ltd. Medule Pharma Pvt. Ltd. Medex Specialities Pvt Ltd. Inhaled Technologies Pvt. Ltd. Lancet Pharma Pvt. Ltd. pursuant to the Scheme of Amalgamation of the Company. Exchan... Read More Ex-date: 10th Sep 2004 Announced on: 11th Sep 2004
Company Profile
Cipla Limited is an India-based global pharmaceutical company. The Company is engaged in manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). The Company operates through two segments: Pharmaceuticals and New ventures.... Read More
Key personnel
Dr. Yusuf K. HamiedD
Non-Executive Chairman of the Board
Mr. Umang VohraD
Global Chief Executive Officer, Managing Director, Executive Director
Mr. Ashish Adukia
Global Chief Financial Officer
Mr. Achin Gupta
Global Chief Executive Officer, Managing Director, Additional Director
Ms. Sneha Hiranandani
Chief Information Officer
Mr. Rajendra Kumar Chopra
Compliance Officer, Company Secretary
Mr. Kamil HamiedD
Non-Executive Director
Mr. Abhijit JoshiD
Non-Executive Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Cipla Ltd.?
The current share price of Cipla Ltd. is ₹ 1,373.50 as of 19 Jan 2026.
What is the PE ratio of Cipla Ltd.?
The Price-to-Earnings (PE) ratio of Cipla Ltd. is 20.40 as of the latest financial data.
What is the ROE and ROCE of Cipla Ltd.?
Cipla Ltd. has a Return on Equity (ROE) of 17.76% and a Return on Capital Employed (ROCE) of 19.42% as per the latest financial reports.
What is the market cap of Cipla Ltd.?
The market capitalization of Cipla Ltd. stands at ₹ 1,10,947.48 Cr.
What is the dividend yield of Cipla Ltd.?
The dividend yield of Cipla Ltd. is 0.93% based on the current market price.
What is the RSI of Cipla Ltd.?
The Relative Strength Index (RSI) of Cipla Ltd. is 25.95.
What is the FII and DII holding in Cipla Ltd.?
Foreign Institutional Investors (FII) hold 24.54% and Domestic Institutional Investors (DII) hold 28.50% of Cipla Ltd. shares.
What sector does Cipla Ltd. belong to?
Cipla Ltd. operates in the Healthcare sector.
What is the beta of Cipla Ltd. stock?
The beta of Cipla Ltd. stock is 0.87, indicating its volatility relative to the broader market.
